AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Raflozol-P Injection

Prescription Icon
Prescription Required

Marketer

Raviolis Healthcare

Salt Composition

Pantoprazole (40mg)

Overview Raflozol-P Injection

Intravenous Raflozol-P is a medication that suppresses gastric acid secretion. Its therapeutic applications encompass acid-related gastrointestinal disorders like gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, offering symptomatic relief and facilitating healing. It's also employed prophylactically against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injectable formulation is administered exclusively by healthcare providers when oral medication is deemed inappropriate. Dosage is individualized based on patient response and condition, with treatment duration determined by the physician. Consistent adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Lifestyle modifications, such as consuming smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods, can enhance treatment efficacy. Commonly reported adverse effects include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal discomfort, and thrombophlebitis. While generally mild, persistent or bothersome side effects warrant medical consultation. Prolonged use, especially exceeding one year or at higher doses, elevates the risk of bone fractures. Discussions with your doctor regarding bone health maintenance, including calcium and vitamin D supplementation, are recommended. Prior to initiating treatment, inform your physician about severe hepatic impairment, HIV medication use, prior allergic reactions to similar medications, or pre-existing osteoporosis. Consult your doctor before use during pregnancy or breastfeeding. Alcohol consumption should be avoided due to its potential to exacerbate symptoms. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.

Primary Ingredients of Raflozol-P Injection

No information provided. Please provide the text you wish me to rephrase.

Uses of Raflozol-P Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Raflozol-P Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Raflozol-P Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Raflozol-P Injection:

This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.

How Raflozol-P Injection works:

Raflozol-P Injection, a proton pump inhibitor, decreases stomach acid production, thereby alleviating heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Raflozol-P Injection use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Raflozol-P Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administration of Raflozol-P Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant exposure to the medication.

DrivingDrivingCONSULT YOUR DOCTOR

Raflozol-P Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Raflozol-P Injection poses no safety concerns for patients with renal impairment, and no dosage modification is advised.

LiverLiverCAUTION

Exercise caution when administering Raflozol-P Injection to patients exhibiting severe hepatic impairment. Dosage modification of Raflozol-P Injection might be necessary. Physician consultation is advised.

What if you forget to take Raflozol-P Injection :

Should you inadvertently skip a Raflozol-P Injection, seek medical advice.

Facts to Know About Raflozol-P Injection

LabelValue
Chemical Classification Benzimidazole Sulfoxide
Developing Habits No.
Treatment Category Gastrointestinal system
Behavioral Class Gastric acid suppressants

FAQs on Raflozol-P Injection

Raflozol-P Injection treats peptic ulcers, reflux esophagitis (GERD), and prevents painkiller-induced acidity. It also treats Zollinger-Ellison syndrome (ZES), a condition involving excessive stomach acid. The injection works by decreasing stomach acid production, providing symptom relief.
Yes, antacids can be taken with Raflozol-P Injection, but allow a two-hour interval between doses.
Expect improvement within 2–3 days, though full effectiveness of Raflozol-P Injection may take up to 4 weeks; some symptoms might persist until then.
Prolonged Raflozol-P Injection treatment may lead to weight gain in some individuals, possibly due to increased appetite following symptom relief. Discuss any weight concerns with your doctor.
Raflozol-P Injection and alcohol should not be consumed together. While alcohol doesn't directly impact Raflozol-P's effectiveness, it can raise stomach acid levels, potentially exacerbating your symptoms.
For optimal absorption, administer Raflozol-P Injection one hour before eating. Avoid spicy, fatty foods, caffeinated beverages (tea, coffee, cola), and alcohol during treatment, as these may exacerbate symptoms.
Raflozol-P Injection is typically prescribed for short-term treatment. Longer-term use, potentially necessary for conditions like peptic ulcer disease or Zollinger-Ellison syndrome, carries a heightened risk of side effects and requires close medical supervision. Always follow your doctor's instructions for using Raflozol-P Injection.
Yes, combining painkillers with Raflozol-P Injection is safe. Raflozol-P Injection protects against painkiller-induced stomach ulcers and acidity. Take Raflozol-P Injection one hour before meals, while painkillers are typically best taken with or after food.
While a single dose of Raflozol-P Injection may be insufficient, relief from heartburn, indigestion, and acid reflux is often achieved within a few doses. Treatment typically lasts only one to two weeks. However, longer-term use may be necessary for conditions like peptic ulcer disease or Zollinger-Ellison syndrome (ZES), as determined by your doctor. If symptoms persist after two weeks of regular use, consult your physician.
Prolonged Raflozol-P Injection use (over 3 months) can cause side effects, most notably low blood magnesium, leading to fatigue, confusion, dizziness, shakiness, muscle twitching, or irregular heartbeat. Extended use (over 1 year) may increase the risk of bone fractures, stomach infections, and vitamin B12 deficiency. Vitamin B12 deficiency can cause anemia, manifesting as fatigue, weakness, paleness, palpitations, shortness of breath, lightheadedness, indigestion, appetite loss, gas, or neurological symptoms like numbness, tingling, and gait problems.
Raflozol-P Injection
42
MRP 49
14% off